WO2013046059A3 - Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose - Google Patents

Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose Download PDF

Info

Publication number
WO2013046059A3
WO2013046059A3 PCT/IB2012/002608 IB2012002608W WO2013046059A3 WO 2013046059 A3 WO2013046059 A3 WO 2013046059A3 IB 2012002608 W IB2012002608 W IB 2012002608W WO 2013046059 A3 WO2013046059 A3 WO 2013046059A3
Authority
WO
WIPO (PCT)
Prior art keywords
tamarind
trehalose
ocular disease
compositions
methods
Prior art date
Application number
PCT/IB2012/002608
Other languages
English (en)
Other versions
WO2013046059A2 (fr
Inventor
Robert C SYKORA
Original Assignee
Sykora Robert C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sykora Robert C filed Critical Sykora Robert C
Publication of WO2013046059A2 publication Critical patent/WO2013046059A2/fr
Publication of WO2013046059A3 publication Critical patent/WO2013046059A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une préparation ophtalmique pour application topique sur l'œil, la préparation étant constituée, entre autres ingrédients, (a) de tamarin et (b) de tréhalose en des quantités suffisantes pour traiter une maladie oculaire caractérisée par une sécheresse oculaire, une inflammation superficielle de l'œil, ou une lésion superficielle de l'œil.
PCT/IB2012/002608 2011-09-27 2012-09-25 Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose WO2013046059A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161539582P 2011-09-27 2011-09-27
US61/539,582 2011-09-27

Publications (2)

Publication Number Publication Date
WO2013046059A2 WO2013046059A2 (fr) 2013-04-04
WO2013046059A3 true WO2013046059A3 (fr) 2013-07-11

Family

ID=47996547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/002608 WO2013046059A2 (fr) 2011-09-27 2012-09-25 Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose

Country Status (1)

Country Link
WO (1) WO2013046059A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014081969A1 (fr) 2012-11-21 2014-05-30 University Of Louisville Research Foundation, Inc Compositions et méthodes de réduction du stress oxydatif
CA3014030C (fr) 2015-02-09 2023-10-03 Ori Braun Compositions ophtalmiques et procedes de reduction des dommages oxydatifs d'un cristallin oculaire
CN108135956B (zh) * 2015-07-13 2021-06-08 东北泰克诺亚奇股份有限公司 视神经保护用组合物
CN114177280A (zh) * 2021-12-17 2022-03-15 上海卫康光学眼镜有限公司 一种含稳定性抗氧化酶的洗眼液及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911933A (en) * 1985-05-29 1990-03-27 Eye Research Institute Of Retina Foundation Non-toxic opthalmic preparations
EP0538313B1 (fr) * 1990-07-06 1999-04-07 Insite Vision, Inc. Suspensions ophtalmiques topiques
US6056950A (en) * 1996-02-05 2000-05-02 Farmigea S.P.A. Ophthalmic solutions viscosified with tamarind seed polysaccharide
US20070077278A1 (en) * 2003-11-10 2007-04-05 Yukiko Sugihara Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US20090118262A1 (en) * 2007-11-01 2009-05-07 Rohrs Brian R Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911933A (en) * 1985-05-29 1990-03-27 Eye Research Institute Of Retina Foundation Non-toxic opthalmic preparations
EP0538313B1 (fr) * 1990-07-06 1999-04-07 Insite Vision, Inc. Suspensions ophtalmiques topiques
US6056950A (en) * 1996-02-05 2000-05-02 Farmigea S.P.A. Ophthalmic solutions viscosified with tamarind seed polysaccharide
US20070077278A1 (en) * 2003-11-10 2007-04-05 Yukiko Sugihara Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US20090118262A1 (en) * 2007-11-01 2009-05-07 Rohrs Brian R Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery

Also Published As

Publication number Publication date
WO2013046059A2 (fr) 2013-04-04

Similar Documents

Publication Publication Date Title
WO2012103186A3 (fr) Composition androgène pour le traitement d'une affection ophtalmique
AR121843A2 (es) Formulación oftálmica y método para mejorar la presbicia
NZ704247A (en) Compositions and treatment for eye diseases and disorders
MY171920A (en) Prevention and treatment of ocular conditions
MY169328A (en) Compositions for the treatment of dry eye
WO2012080497A3 (fr) Procédés de traitement et de prévention de maladies oculaires
EP2624916A4 (fr) Compositions et méthodes de traitement d'un dème oculaire, de néovascularisation et de maladies associées
MX2015002239A (es) Formulacion oftalmica de lipido polioxilo o de acido graso polioxilo y tratamiento de padecimientos oculares.
WO2013103919A8 (fr) Compositions et procédés de traitement de troubles métaboliques
WO2013180834A3 (fr) Compositions et procédés d'inhibition de masp-1 et/ou masp-3 pour le traitement l'hémoglobinurie paroxysmique nocturne
CL2013002934A1 (es) Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma.
WO2011116020A3 (fr) Formulations ophthalmiques de cétirizine et leurs méthodes d'utilisation
WO2012097272A8 (fr) Compositions d'hydrogel stable incluant des additifs
WO2015099838A3 (fr) Compositions et procédés de traitement de troubles oculaires
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
WO2013046059A3 (fr) Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose
EP2575842A4 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
WO2014145236A3 (fr) Utilisation de sdf-1 d'atténuation de formation de cicatrice
WO2013059233A3 (fr) Compositions thermosensibles à usage dermatologique et méthodes associées
WO2012006585A3 (fr) Utilisation de l'interleukine-15 dans le traitement de maladies cardiovasculaires
WO2014116015A3 (fr) Composition pour la prévention de la maladie d'alzheimer, contenant un sel de bambou pourpre, et procédé de préparation de sel de bambou pourpre
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
BR112014020424A2 (pt) ponta de fragmentação, dispositio de cirurgia intra-ocular fornecido com as mesmas, método para suprimir ocorrência de cavitação e método de cirurgia de catarata

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12835737

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12835737

Country of ref document: EP

Kind code of ref document: A2